345 related articles for article (PubMed ID: 24911925)
1. Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.
Chicaybam L; Bonamino MH
Int Rev Immunol; 2014 Oct; 33(5):402-16. PubMed ID: 24911925
[TBL] [Abstract][Full Text] [Related]
2. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
3. Shared target antigens on cancer cells and tissue stem cells: go or no-go for CAR T cells?
Hombach AA; Abken H
Expert Rev Clin Immunol; 2017 Feb; 13(2):151-155. PubMed ID: 27546707
[TBL] [Abstract][Full Text] [Related]
4. Adoptive T-cell therapy for cancer: The era of engineered T cells.
Bonini C; Mondino A
Eur J Immunol; 2015 Sep; 45(9):2457-69. PubMed ID: 26202766
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeting domains for chimeric antigen receptor T cells.
Bezverbnaya K; Mathews A; Sidhu J; Helsen CW; Bramson JL
Immunotherapy; 2017 Jan; 9(1):33-46. PubMed ID: 28000526
[TBL] [Abstract][Full Text] [Related]
6. Antigen choice in adoptive T-cell therapy of cancer.
Offringa R
Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
[TBL] [Abstract][Full Text] [Related]
7. Improving the efficacy and safety of engineered T cell therapy for cancer.
Shi H; Liu L; Wang Z
Cancer Lett; 2013 Jan; 328(2):191-7. PubMed ID: 23022475
[TBL] [Abstract][Full Text] [Related]
8. Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseases.
Hombach A; Pohl C; Reinhold U; Abken H
Hybridoma; 1999 Feb; 18(1):57-61. PubMed ID: 10211789
[TBL] [Abstract][Full Text] [Related]
9. Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.
Peinert S; Kershaw MH; Prince HM
Immunotherapy; 2009 Nov; 1(6):905-12. PubMed ID: 20635906
[No Abstract] [Full Text] [Related]
10. Adoptive T-cell therapy of cancer.
Yee C
Hematol Oncol Clin North Am; 2006 Jun; 20(3):711-33. PubMed ID: 16762731
[TBL] [Abstract][Full Text] [Related]
11. Current strategies to improve the safety of chimeric antigen receptor (CAR) modified T cells.
Yang QY; Yang JD; Wang YS
Immunol Lett; 2017 Oct; 190():201-205. PubMed ID: 28837818
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with gene-modified T cells: limiting side effects provides new challenges.
Stauss HJ; Morris EC
Gene Ther; 2013 Nov; 20(11):1029-32. PubMed ID: 23804078
[TBL] [Abstract][Full Text] [Related]
13. Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.
Chicaybam L; Sodré AL; Bonamino M
Int Rev Immunol; 2011; 30(5-6):294-311. PubMed ID: 22053970
[TBL] [Abstract][Full Text] [Related]
14. Genetic redirection of T cells for cancer therapy.
Westwood JA; Kershaw MH
J Leukoc Biol; 2010 May; 87(5):791-803. PubMed ID: 20179152
[TBL] [Abstract][Full Text] [Related]
15. Preclinical development of T cell receptor gene therapy.
Bendle GM; Haanen JB; Schumacher TN
Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326
[TBL] [Abstract][Full Text] [Related]
16. Unleash the power of the mighty T cells-basis of adoptive cellular therapy.
Sukari A; Abdallah N; Nagasaka M
Crit Rev Oncol Hematol; 2019 Apr; 136():1-12. PubMed ID: 30878123
[TBL] [Abstract][Full Text] [Related]
17. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies.
Gill S; June CH
Immunol Rev; 2015 Jan; 263(1):68-89. PubMed ID: 25510272
[TBL] [Abstract][Full Text] [Related]
18. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes.
Shirasu N; Kuroki M
Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678
[TBL] [Abstract][Full Text] [Related]
19. Engineering T cells for adoptive therapy: outsmarting the tumor.
Kunert A; Debets R
Curr Opin Immunol; 2018 Apr; 51():133-139. PubMed ID: 29579622
[TBL] [Abstract][Full Text] [Related]
20. Redirected T cells in cancer therapy.
Sangiolo D
Expert Opin Biol Ther; 2015; 15(12):1667-70. PubMed ID: 26515608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]